Connect with us

Health

New Ozempic-alternative diabetes pill burns fat without muscle loss, study suggests

Published

on

New Ozempic-alternative diabetes pill burns fat without muscle loss, study suggests

NEWYou can now listen to Fox News articles!

Scientists in Sweden have created a new pill designed to help the body burn fat and control blood sugar in a different way than popular GLP-1 drugs, like Ozempic.

Advertisement

While injectable GLP-1s work by suppressing appetite, this new treatment boosts metabolism in the muscles.

A study led by researchers at Karolinska Institutet and Stockholm University included both an early animal study and a human clinical trial with 48 healthy adults and 25 people with type 2 diabetes, according to a press release.

NEW WEIGHT-LOSS SHOT SHOWS MAJOR FAT REDUCTION, BUT EXPERTS URGE CAUTION

The new oral medication was found to successfully control blood glucose, boost fat burning and retain muscle mass in animals, while getting high marks for tolerability and safety in humans.

It was also found to have fewer side effects than GLP-1s like semaglutides and tirzepatides, which are known to cause appetite loss, gastrointestinal distress and muscle wasting, the researchers noted.

Advertisement

While injectable GLP-1s work by suppressing appetite, this new treatment boosts metabolism in the muscles. (iStock)

The experimental medication uses a new form of beta-2 agonist that benefits muscle function while also avoiding overstimulation of the heart, which has been identified as a potential safety concern of older versions.

The findings were published this week in the journal Cell.

WEIGHT-LOSS DRUGS NOW LINKED TO CANCER PROTECTION IN WOMEN, MAJOR NEW STUDY REVEALS

Because the new oral drug acts via a different mechanism than appetite-suppressing medications, it could be used alone or in combination with GLP-1s, the researchers noted.

Advertisement

“Our results point to a future where we can improve metabolic health without losing muscle mass,” said Tore Bengtsson, professor at the Department of Molecular Bioscience at Wenner-Gren Institute, Stockholm University, in the release. “Muscles are important in both type 2 diabetes and obesity, and muscle mass is also directly correlated with life expectancy.”

“Muscles are important in both type 2 diabetes and obesity, and muscle mass is also directly correlated with life expectancy.” (iStock)

This medication has the potential to be of “great importance” for patients with type 2 diabetes and obesity, according to Shane C. Wright, assistant professor at the Department of Physiology and Pharmacology at Karolinska Institutet.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Our substance appears to promote healthy weight loss and, in addition, patients do not have to take injections,” he added.

Advertisement

Dr. Trey Wickham, interim chief of the Division of Endocrinology, Diabetes & Metabolism at VCU Health in Richmond, Virginia, was not involved in the study but shared his reaction to the publication in the journal Cell.

“Our results point to a future where we can improve metabolic health without losing muscle mass.”

“This compound’s mechanism of action could address some specific metabolic concerns with previous weight reduction therapies, such as the loss of both muscle and fat tissue,” Wickham told Fox News Digital.  

“Although the reported preliminary results are interesting, rigorous testing involving larger longitudinal trials are necessary to ensure human long-term safety and understand the potential role of this compound in the comprehensive, evidence-based treatment of obesity and diabetes.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Advertisement

The study had some limitations, the researchers noted, chiefly that the preclinical studies in mice fail to capture the “complex nature of these diseases” in humans.

Structural studies are needed to understand exactly how the drug works.

“This compound’s mechanism of action could address some specific metabolic concerns with previous weight reduction therapies, such as the loss of both muscle and fat tissue,” a doctor said. (iStock)

“Our phase 1 data show that compound 15 is well-tolerated; however, conclusive clinical efficacy data (on how the drug controls glucose metabolism) are currently still lacking.”

CLICK HERE FOR MORE HEALTH STORIES

Advertisement

Looking ahead, the company that developed the drug, Atrogi AB, plans to conduct a larger phase 2 clinical trial with a larger, more diverse population, including people with obesity.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The study was supported in part by the Swedish Research Council, the Swedish Society for Medical Research and the Novo Nordisk Foundation.

Uppsala University, University of Copenhagen, Monash University and University of Queensland all collaborated with the lead researchers.

Advertisement

Health

The Best Time To Drink Coffee for Weight Loss and a Faster Metabolism

Published

on

The Best Time To Drink Coffee for Weight Loss and a Faster Metabolism


Advertisement




The Best Time To Drink Coffee for Weight Loss and Fat Burn | Woman’s World




















Advertisement





Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

‘SuperAgers’ stay mentally sharp well past 80, as scientists reveal the reason

Published

on

‘SuperAgers’ stay mentally sharp well past 80, as scientists reveal the reason

NEWYou can now listen to Fox News articles!

Top stories

→ Some 80-year-olds still have razor-sharp brains — and now scientists know why

→ One father’s nightly bathroom habit was missed sign of common cancer

→ 5 ways to preserve vision as you age, according to an ophthalmologist

SuperAger Ralph Rehbock sits with his wife in his home.  (Shane Collins, Northwestern University)

Advertisement

On the lookout

→ Heart disease threat projected to climb sharply for key demographic

→ Heavy snow is recipe for serious heart attack risk, experts say

→ Flu season could linger into spring as doctors warn of second wave

A doctor says the second wave of flu season may be worse than previous years. (iStock)

Conversation starters

→ One type of olive oil has a surprising effect on brainpower in aging adults

Advertisement

→ Common vision issue linked to type of lighting used in homes

→ Some supplements may pose risks for people with diabetes, experts say

Medical advances

→ Alzheimer’s symptoms could be predicted years in advance through one simple test

→ Combination nasal spray vaccine could protect against COVID, flu and pneumonia

→ Weight-loss medications could impact sexual health in unexpected ways

Advertisement

Stat of the week

More than 59% of women may have high blood pressure by 2050, according to a new report from the American Heart Association.

CLICK HERE FOR MORE HEALTH STORIES

Advertisement
Continue Reading

Health

Heart disease threat projected to climb sharply for key demographic

Published

on

Heart disease threat projected to climb sharply for key demographic

NEWYou can now listen to Fox News articles!

A new report by the American Heart Association (AHA) included some troubling predictions for the future of women’s health.

The forecast, published in the journal Circulation on Wednesday, projected increases in various comorbidities in American females by 2050.

More than 59% of women were predicted to have high blood pressure, up from less than 49% currently.

The review also projected that more than 25% of women will have diabetes, compared to about 15% today, and more than 61% will have obesity, compared to 44% currently.

Advertisement

As a result of these risk factors, the prevalence of cardiovascular disease and stroke is expected to rise to 14.4% from 10.7%.

The prevalence of cardiovascular disease and stroke in women is expected to rise to 14.4% from 10.7% by 2050. (iStock)

Not all trends were negative, as unhealthy cholesterol prevalence is expected to drop to about 22% from more than 42% today, the report stated.

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Dr. Elizabeth Klodas, a cardiologist and founder of Step One Foods in Minnesota, commented on these “jarring findings.”

Advertisement

“The fact that on our current trajectory, cardiometabolic disease is projected to explode in women within one generation should be a huge wake-up call,” she told Fox News Digital.

NEARLY 90% OF AMERICANS AT RISK OF SILENT DISEASE — HERE’S WHAT TO KNOW

“Hypertension, diabetes, obesity — these are all major risk factors for heart disease, and we are already seeing what those risks are driving. Heart disease is the No. 1 killer of women, eclipsing all other causes of death, including breast cancer.”

Cardiovascular disease is the leading cause of death for women in the U.S. and around the world. (iStock)

Klodas warned that heart disease starts early, progresses “stealthily,” and can present “out of the blue in devastating ways.”

Advertisement

The AHA published another study on Thursday revealing one million hospitalizations, showing that heart attack deaths are climbing among adults below the age of 55.

The more alarming finding, according to Klodas, is that young women were found more likely to die after their first heart attack than men of the same age.

DOCTOR SHARES 3 SIMPLE CHANGES TO STAY HEALTHY AND INDEPENDENT AS YOU AGE

“This is all especially tragic since heart disease is almost entirely preventable,” she said. “The earlier you start, the better.”

Children can show early evidence of plaque deposition in their arteries, which can be reversed through lifestyle changes if “undertaken early enough and aggressively enough,” according to the expert.

Advertisement

Moving more is one part of protecting a healthy heart, according to experts. (iStock)

Klodas suggested that rising heart conditions are associated with traditional risk factors, like smoking, high blood pressure, high cholesterol, diabetes, obesity and a sedentary lifestyle.

CLICK HERE FOR MORE HEALTH STORIES

Doctors are also seeing higher rates of preeclampsia, or high blood pressure during pregnancy, as well as gestational diabetes. Klodas noted that these are sex-specific risk factors that don’t typically contribute to complications until after menopause.

The best way to protect a healthy heart is to “do the basics,” Klodas recommended, including the following lifestyle habits.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Klodas especially emphasized making improvements to diet, as the food people eat affects “every single risk factor that the AHA’s report highlights.”

“High blood pressure, high blood sugar, high cholesterol, excess weight – these are all conditions that are driven in part or in whole by food,” she said. “We eat multiple times every single day, which means what we eat has profound cumulative effects over time.”

“Even a small improvement in dietary intake, when maintained, can have a massive positive impact on health,” a doctor said. (iStock)

“Even a small improvement in dietary intake, when maintained, can have a massive positive impact on health.”

Advertisement

The doctor also recommends changing out a few snacks per day for healthier choices, which has been proven to “yield medication-level cholesterol reductions” in a month.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

“Keep up that small change and, over the course of a year, you could also lose 20 pounds and reduce your sodium intake enough to avoid blood pressure-lowering medications,” Klodas added.

“Women should not view the AHA report as inevitable. We have power over our health destinies. We just need to use it.”

Advertisement

Related Article

3 simple lifestyle changes could add almost a decade to your life, research shows
Continue Reading

Trending